EGFR and pulmonary arterial hypertension: Oral administration of an EGFR inhibitor induced regression of PAH in rats [57], subcutaneous injection of a pan EGFR inhibitor attenuated pulmonary vascular remodeling [56], and EGFR antagonists reduced RVH in experimental PAH [58].